Latest filing published 28 Dec 2020 for Portage Biotech Inc..
Gregory Bailey discloses dealings in Portage Biotech Inc. to SEDI. We count 31 filings; the first trade dates from 15 January 2016 and the latest from 20 December 2020.
The open-market record is one-sided, with 20 purchases worth €665k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 2 option exercises.
In size, the median ticket on the buying side is €32k. No cluster: in 20 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 28 December 2020: a transaction, in Portage Biotech Inc. The most recent open-market purchase was published on 9 June 2017, 3,427 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations